Basically we licenced our patents to Tigenix / Takeda for the Cx601 / Darvadstrocel / Alofisel MSC cell line.
The trials were done in Spain lead by Prof Damian Garcia-Olmo at the Health Research Institute Foundation Jimenez Diaz (IIS-FJD) Madrid, Spain and approved by the EMA.
https://www.clinicaltrialsarena.com/projects/alofisel-darvadstrocel-treatment-complex-perianal-fistulas-crohns-disease/
No idea what the FDA is going to do.
Basically we licenced our patents to Tigenix / Takeda for the...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.045(3.83%) |
Mkt cap ! $1.290B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.19 | $1.12 | $12.16M | 10.69M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 50650 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 124897 | 8 |
View Market Depth
| Last trade - 16.10pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.13 |
Change
-0.045 ( 4.33 %) |
||||
| Open | High | Low | Volume | ||
| $1.17 | $1.17 | $1.12 | 1447014 | ||
| Last updated 15.59pm 08/05/2024 ? | |||||
| MSB (ASX) Chart |